Antituberculosis treAtment-induced HepAtotoxicity: From bencH to bedside

commonly encountered adverse effect withantituberculosis treatment.6-8 Recent developments especially in the field of molecular biology have expanded our views on the understanding of drug-induced liver damage. 9,10 In this paper, we have attempted to summarise the current understanding of the pathogenetic mechanismsof DIH as it has been viewed from the laboratory bench and the bedsideimplications of these observations to the practicingclinician with particular reference toantituberculosis drugs. MEcHAnISMS oF druG‐InducEd